|
February 13, 2012
|
| 08:05 EDT |  | AMLN |
|
|
February 9, 2012
|
| 16:27 EDT |  | AMLN |
| theflyonthewall.com: | Leerink's biotech and pharmaceuticals analysts hold a conference call | | Biotech Analysts Schimmer and Liang, along with Pharmaceuticals Analyst Fernandez, review the reimbursement process for drugs in France on an Analyst/Industry conference call. Relevant covered companies ACOR, AMGN, AMLN, AUXL, BIIB, BMY, GILD, HGSI, ITMN, JNJ, NVS, PFE and VRTX may be included on the Analyst/Industry conference call to be held on February 10 at 11 am. :theflyonthewall.com |
|
|
February 7, 2012
|
| 09:57 EDT |  | AMLN |
|
| 09:24 EDT | | AMLN |
| theflyonthewall.com: | Pre-market top 5 gainers | | The following stocks were the top percentage gainers before the open on solid volume of at least 50,000 shares, trading at over $10. CSTR 18%, AMLN 4.8%, PRGO 4.2%, HGSI 2.3%, DNDN 1%. :theflyonthewall.com |
|
| 07:58 EDT |  | AMLN |
| theflyonthewall.com: | Amylin price target raised to $19 from $17 at RW Baird | | Baird raised its price target on Amylin following Q4 results. The firm cited the potential for a successful US partnership transaction and the launch of Bydureon on February 17. Shares are Outperform rated. :theflyonthewall.com |
|
| 07:46 EDT | | AMLN |
|
| 07:04 EDT | | AMLN |
|
| 07:02 EDT |  | AMLN |
| theflyonthewall.com: | Amylin sees 2012 non-GAAP operating loss $20M-$40M | | The company sees 2012 GAAP operating expense of $600M-$625M. Guidance was issued on Amylin's earnings conference call last night. :theflyonthewall.com |
|
|
February 6, 2012
|
| 16:48 EDT | | AMLN |
|
| 16:45 EDT | | AMLN |
|
| 16:44 EDT | | AMLN |
|
| 16:44 EDT | | AMLN |
| theflyonthewall.com: | Amylin reports Q4 EPS ($3.15) vs. consensus (8c) | | Reports Q4 revenue $164.94M vs. consensus $163.64M :theflyonthewall.com |
|
| 09:01 EDT | | AMLN |
| theflyonthewall.com: | Amylin breaks lower in pre-market trading, support is at $16.29, then $15.55 | | :theflyonthewall.com |
|
| 08:14 EDT | | AMLN |
|
|
January 31, 2012
|
| 11:21 EDT | | AMLN |
|
|
January 30, 2012
|
| 12:14 EDT |  | AMLN |
|
| 12:00 EDT | | AMLN |
|
| 10:02 EDT | | AMLN |
|
| 09:19 EDT | | AMLN |
|
| 09:06 EDT |  | AMLN |
| theflyonthewall.com: | Amylin downgraded to Neutral from Buy at Summer Street | | Summer Street downgraded Amylin following approval of Bydureon. :theflyonthewall.com |
|
| 09:00 EDT | | AMLN |
| theflyonthewall.com: | Amylin rises 15.6% | | Amylin is up 15.6%, or $1.89, to $14.03 :theflyonthewall.com |
|
| 08:14 EDT | | AMLN |
|
| 08:07 EDT | | AMLN |
|
| 07:59 EDT | | AMLN |
|
| 07:57 EDT | | AMLN |
|
Subscribe for More Information